Yuyu Pharma Pref Shs (000225) Stock Price & News

000225:KRX

Yuyu Pharma Pref Shs

₩3,600.00

+0.14%

(+5.00) 1D

Oct 19, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 000225...

Open

₩3,595

High

₩3,600

Low

₩3,540

Mkt. cap

70.90B

Avg. vol.

9.56K

Volume

1.62K

Dividend

3.19%

Quarterly dividend

₩29

Ex-dividend date

Dec 27, 2024

P/E ratio

5.38

52-wk high

₩5,700

52-wk low

₩3,345

EPS

₩669

Shares outstanding

2.27M

No. of employees

243

Open

₩3,595

High

₩3,600

Low

₩3,540

Mkt. cap

70.90B

Avg. vol.

9.56K

Volume

1.62K

Dividend

3.19%

Quarterly dividend

₩29

Ex-dividend date

Dec 27, 2024

P/E ratio

5.38

52-wk high

₩5,700

52-wk low

₩3,345

EPS

₩669

Shares outstanding

2.27M

No. of employees

243

Related stocks

Yuhan Corp Preference Shares

₩71,300.00

+6.74%

000240

Hankook & Company Co Ltd

₩26,350.00

+0.19%

News stories

From web sources and news partners

The Motley Fool

3 minutes ago

The S&P 500's Worst Day Was 39 Years Ago Today. Should You Buy When Stocks Crash?

Investing.com

15 minutes ago

BofA upgrades Dow stock rating on Middle East oil concerns

MarketWatch

58 minutes ago

The S&P 500 is masking a hidden market pullback. Why Morgan Stanley says an index retreat would signal a buying opportunity.

24/7 Wall St.

25 minutes ago

A Repeat Of 'Black Monday' Would Send The S&P 500 Down More Than 1,500 Points And Wipe Out More Than $13 Trillion In Stock Market Value

About Yuyu Pharma Pref Shs

CEO-

Employees243

Founded1941

Headquarters-

SectorPharmaceutical industry

Websiteyuyu.co.kr

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	37.79B	34.34B	35.54B	36.70B
Cost of goods sold	23.00B	22.54B	21.04B	22.11B
Cost of revenue	23.00B	22.54B	21.04B	22.11B
Research and development expenses	914.90M	1.15B	703.42M	781.89M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	8.71B	10.17B	8.95B	9.33B
Operating expense	9.81B	11.93B	10.19B	10.59B
Total operating expenses	32.81B	34.47B	31.24B	32.69B
Operating income	4.99B	-129.07M	4.30B	4.00B
Other non operating income	56.65M	-1.13B	863.61M	-184.40M
EBT including unusual items	4.82B	202.03M	3.97B	4.13B
EBT excluding unusual items	4.77B	-1.11B	4.99B	3.68B
Income tax expense	504.29M	-1.00B	620.45M	574.52M
Effective tax rate	10.46%	-496.97%	15.62%	13.91%
Other operating expenses	18.27M	76.24M	40.94M	36.86M
Net income	3.98B	1.39B	3.49B	3.65B
Net profit margin	10.52%	4.03%	9.82%	9.95%
Earnings per share	-	-	-	-
Interest and investment income	136.07M	529.96M	286.44M	226.76M
Interest expense	-540.35M	-547.07M	-474.32M	-436.45M
Net interest expenses	-404.28M	-17.11M	-187.88M	-209.69M
Depreciation and amortization charges	320.96M	403.34M	334.87M	409.27M
EBITDA	6.34B	1.33B	5.68B	5.46B
Gain or loss from assets sale	-13.34M	-	-499.00K	-3.19M

Finance

Ask anything